GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice
Key Points:
- In recent years, there has been a remarkable resurgence in drugs to treat obesity and its related co-morbidities. A standout example is tirzepatide, a co-agonist at the receptors for GLP-1 and GIP. In